Abstract 18569: Patient and Provider Factors Associated With the Initiation of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in the Year Post FDA Approval for HFpEF and HFmrEF
Year: 2023
Type: conference-abstract
Source: Circulation
Institution: Cleveland Clinic
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389945203
